To recover your password please fill in your email address
Please fill in below form to create an account with us
Sydney researchers are testing whether an existing medication could be repurposed to treat sarcoma.
New study to influence clinical practice globally Changing how pre-term babies' umbilical cords are clamped could improve outcomes and save babies lives, prompting an update of the international guidelines that inform global practice.
The CLARITY 2.0 study looks at the Dimerix lead candidate DMX-200 combined with Angiotensin Receptor Blockers to treat respiratory issues associated with COVID-19. The study will recruit patients at an early stage of respiratory complications, prior to the onset of Acute Respiratory Distress Syndrome (ARDS).
ENZAMET scooped the pool at the ACTA Trial of the Year Awards Ceremony winning the 2020 ACTA Trial of the Year Award, the ACTA STInG Award for Excellence in Trial Statistics and the Consumer Involvement Award. A fantastic achievement and the first trial to win all three awards!
Australian medical research is at risk of punching below its weight unless more attention is paid to the discipline of biostatistics.
The CTC’s Prof Martin Stockler has received the prestigious MOGA Novartis Cancer Achievement Award for his outstanding contribution to medical oncology in Australia.
A new trial being undertaken by the NHMRC Clinical Trials Centre is photographing the back of the eye of those living with diabetes to help them avoid losing their vision and the risks of amputation and heart disease.
Statin therapy is safe and effective in older people over 75 years and reduces major cardiovascular events such as heart attacks and strokes, according to new research by the University of Sydney's Clinical Trials Centre published in The Lancet.